Clinical Trial Update: The Gilenya Pregnancy Registry

View source ↗

Summary

A completed observational pregnancy registry evaluating outcomes in patients exposed to fingolimod (Gilenya) for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: COMPLETED